Summit Therapeutics
Yahoo Finance • 15 days ago
At a glance: stocks gapping down premarket
[Wall Street-Street Sign] P_Wei/E+ via Getty Images Here's a quick look at the stocks that are seeing gap-down moves before the bell Friday. Stock index futures were higher on Friday as the stock market hoped to recover from Thursday's s... Full story
Yahoo Finance • 16 days ago
After-Hours Earnings Report for July 23, 2026 : INTC, NEM, FIX, DLR, EW, HIG, VRSN, OVV, SSNC, DECK, SMMT, SSB
The following companies are expected to report earnings after hours on 07/23/2026. Visit our Earnings Calendar for a full list of expected earnings releases. Intel Corporation (INTC)is reporting for the quarter ending June 30, 2026. Th... Full story
Yahoo Finance • 16 days ago
Here are the major earnings after the close Thursday
Major earnings expected after the bell on Thursday include: * Intel Corporation (INTC [https://seekingalpha.com/symbol/INTC]) * Newmont Corporation (NEM [https://seekingalpha.com/symbol/NEM]) * Digital Realty Trust (DLR [https://see... Full story
Yahoo Finance • last month
Recursion Pharmaceuticals vs. Summit Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
Choosing between Recursion Pharmaceuticals (NASDAQ:RXRX) and Summit Therapeutics (NASDAQ:SMMT) requires weighing the broad potential of artificial intelligence against the specific clinical prospects of a high-potential oncology drug candi... Full story
Yahoo Finance • last month
The New War on Cancer: Four Public Companies Helping Lead a Medical Revolution
DENVER, June 25, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) – Cancer treatment is undergoing one of the most significant transformations in modern medical history. For decades, physicians relied primarily on surgery, radiation, and ch... Full story
Yahoo Finance • 2 months ago
Summit Therapeutics (SMMT): A $500 Million Stock Offering Pulled Just One Day After Filing
Summit Therapeutics Inc. (NASDAQ:SMMT) is one of the most promising healthcare stocks according to Wall Street analysts. On June 10, Summit Therapeutics Inc. (NASDAQ:SMMT) withdrew a $500 million proposed underwritten public offering it ha... Full story
Yahoo Finance • 2 months ago
Summit rebounds after nearly $50M insider purchase
[$10 Banknote Stacking, Green Up Arrow Rise] spawns * Shares of Summit Therapeutics (SMMT [https://seekingalpha.com/symbol/SMMT]) bounced back, recovering recent losses on Friday after the cancer drug developer’s co-CEO Robert Duggan di... Full story
Yahoo Finance • 2 months ago
Stocks Settle Sharply Lower on Escalating Middle East Tensions
The S&P 500 Index ($SPX) (SPY) on Wednesday closed down -1.62%, the Dow Jones Industrial Average ($DOWI) (DIA) closed down -1.87%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down -1.98%. June E-mini S&P futures (ESM26) fell -1.62%, and... Full story
Yahoo Finance • 2 months ago
Stocks Resume Decline as Chipmakers and AI Companies Fall
The S&P 500 Index ($SPX) (SPY) today is down -0.61%, the Dow Jones Industrial Average ($DOWI) (DIA) is down -0.88%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.80%. June E-mini S&P futures (ESM26) are down -0.71%, and June E-mini Na... Full story
Yahoo Finance • 2 months ago
Stocks Fall on Weakness in Tech and Trucking Companies
The S&P 500 Index ($SPX) (SPY) today is down -0.28%, the Dow Jones Industrial Average ($DOWI) (DIA) is down -0.38%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.28%. June E-mini S&P futures (ESM26) are down -0.25%, and June E-mini Na... Full story
Yahoo Finance • 2 months ago
Summit Therapeutics Announces Proposed Public Offering of Common Stock
MIAMI, June 09, 2026--(BUSINESS WIRE)--Summit Therapeutics Inc. (Nasdaq: SMMT) ("Summit," "we," or the "Company") today announced that it has commenced an underwritten public offering of $500.0 million of shares of its common stock. All of... Full story
Yahoo Finance • 2 months ago
Summit Therapeutics COO, CFO & Director Acquires 1.6% More Stock
Those following along with Summit Therapeutics Inc. (NASDAQ:SMMT) will no doubt be intrigued by the recent purchase of shares by Manmeet Soni, COO, CFO & Director of the company, who spent a stonking US$722k on stock at an average price of... Full story
Yahoo Finance • 2 months ago
Summit Therapeutics (SMMT) Reveals Phase II AK112-206 Trial Data
Summit Therapeutics Inc. (NASDAQ:SMMT) is one of the 10 best large cap stocks under $30 with highest upside potential. On May 31, Summit Therapeutics Inc. (NASDAQ:SMMT) presented new clinical data from the international Phase II AK112-206... Full story
Yahoo Finance • 2 months ago
Cantor Fitzgerald Maintains Overweight Rating on Summit Therapeutics (SMMT) Amid Mixed Clinical Developments
Summit Therapeutics Inc. (NASDAQ:SMMT) ranks among the best short squeeze stocks to invest in. On May 22, Cantor Fitzgerald restated its Overweight rating for Summit Therapeutics Inc. (NASDAQ:SMMT). The firm addressed concerns about the HA... Full story
Yahoo Finance • 2 months ago
Ivonescimab with Chemotherapy Demonstrated a Statistically Significant Overall Survival Benefit Compared to Tislelizumab Plus Chemotherapy in 1L Treatment of Patients with Squamous NSCLC in the HARMONi-6 Study Conducted by Akeso in China
Ivonescimab Plus Chemotherapy Reduced the Risk of Death by 34% Compared to Tislelizumab Plus Chemotherapy; Hazard Ratio 0.66 First Regimen to Achieve a Statistically Significant and Clinically Meaningful Overall Survival Benefit over an a... Full story
Yahoo Finance • 3 months ago
What to Know About This Fund's $6.6 Million UroGen Sale After a 600% Stock Surge
Superstring Capital Management cut its stake in UroGen Pharma Ltd. (NASDAQ:URGN), selling 330,983 shares in the first quarter in an estimated $6.64 million trade based on average quarterly pricing, according to a May 14, 2026, SEC filing.... Full story
Yahoo Finance • 3 months ago
Why a Biotech Fund Opened a New $6 Million Position in Vir Amid a 99% Stock Rally
Superstring Capital Management disclosed a new position in Vir Biotechnology(NASDAQ:VIR), acquiring 730,548 shares in the first quarter. The estimated transaction value was $5.82 million based on quarterly average pricing. What happened... Full story
Yahoo Finance • 3 months ago
Stocks Climb on US-Iran Peace Hopes and Strength in Chipmakers
The S&P 500 Index ($SPX) (SPY) today is up +0.50%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.63%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.73%. June E-mini S&P futures (ESM26) are up +0.47%, and June E-mini Nasdaq fut... Full story
Yahoo Finance • 3 months ago
Stocks Supported by US-Iran Peace Deal Optimism
The S&P 500 Index ($SPX) (SPY) today is up +0.54%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.70%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.53%. June E-mini S&P futures (ESM26) are up +0.50%, and June E-mini Nasdaq fut... Full story
Yahoo Finance • 3 months ago
Is Daraxonrasib’s Phase 3 Pancreatic Cancer Data And EQRx Deal Altering The Investment Case For Revolution Medicines (RVMD)?
Earlier in May 2026, Revolution Medicines reported that its RAS(ON) inhibitor daraxonrasib delivered what it called unprecedented overall survival benefit in the pivotal Phase 3 RASolute 302 trial for metastatic pancreatic cancer, while al... Full story
- RVMD